326 related articles for article (PubMed ID: 21295813)
21. Nephrolithiasis after bariatric surgery for obesity.
Lieske JC; Kumar R; Collazo-Clavell ML
Semin Nephrol; 2008 Mar; 28(2):163-73. PubMed ID: 18359397
[TBL] [Abstract][Full Text] [Related]
22. Determinants of urolithiasis in patients with intestinal fat malabsorption.
Siener R; Petzold J; Bitterlich N; Alteheld B; Metzner C
Urology; 2013 Jan; 81(1):17-24. PubMed ID: 23200965
[TBL] [Abstract][Full Text] [Related]
23. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.
Park AM; Storm DW; Fulmer BR; Still CD; Wood GC; Hartle JE
J Urol; 2009 Nov; 182(5):2334-9. PubMed ID: 19762043
[TBL] [Abstract][Full Text] [Related]
24. Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients.
Topart P; Becouarn G; Ritz P
Surg Obes Relat Dis; 2013; 9(4):526-30. PubMed ID: 22498360
[TBL] [Abstract][Full Text] [Related]
25. Intestinal absorption of oxalate and calcium in patients with jejunoileal bypass.
Lindsjö M; Danielson BG; Fellström B; Lithell H; Ljunghall S
Scand J Urol Nephrol; 1989; 23(4):283-9. PubMed ID: 2595324
[TBL] [Abstract][Full Text] [Related]
26. Bariatric Surgery in Patients with a History of Nephrolithiasis: 24-h Urine Profiles and Radiographic Changes After Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy.
Uy M; Di Lena R; Hoogenes J; Alharbi B; Gmora S; Shayegan B; Matsumoto ED
Obes Surg; 2021 Apr; 31(4):1673-1679. PubMed ID: 33387265
[TBL] [Abstract][Full Text] [Related]
27. Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors.
Kleinman JG
Kidney Int; 2007 Jul; 72(1):8-10. PubMed ID: 17597787
[TBL] [Abstract][Full Text] [Related]
28. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
29. Lessons from rodent gastric bypass model of enteric hyperoxaluria.
Kwenda EP; Rabley AK; Canales BK
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):400-406. PubMed ID: 32398610
[TBL] [Abstract][Full Text] [Related]
30. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
31. Hyperoxaluria after modern bariatric surgery: case series and literature review.
Whitson JM; Stackhouse GB; Stoller ML
Int Urol Nephrol; 2010 Jun; 42(2):369-74. PubMed ID: 19572208
[TBL] [Abstract][Full Text] [Related]
32. Nephrolithiasis after bariatric surgery: A review of pathophysiologic mechanisms and procedural risk.
Bhatti UH; Duffy AJ; Roberts KE; Shariff AH
Int J Surg; 2016 Dec; 36(Pt D):618-623. PubMed ID: 27847289
[TBL] [Abstract][Full Text] [Related]
33. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass.
Odstrcil EA; Martinez JG; Santa Ana CA; Xue B; Schneider RE; Steffer KJ; Porter JL; Asplin J; Kuhn JA; Fordtran JS
Am J Clin Nutr; 2010 Oct; 92(4):704-13. PubMed ID: 20739420
[TBL] [Abstract][Full Text] [Related]
34. Urolithiasis risk factors in the bariatric population undergoing gastric bypass surgery.
Wu JN; Craig J; Chamie K; Asplin J; Ali MR; Low RK
Surg Obes Relat Dis; 2013; 9(1):83-7. PubMed ID: 22100051
[TBL] [Abstract][Full Text] [Related]
35. The effect of bariatric surgery on intestinal absorption and transit time.
Carswell KA; Vincent RP; Belgaumkar AP; Sherwood RA; Amiel SA; Patel AG; le Roux CW
Obes Surg; 2014 May; 24(5):796-805. PubMed ID: 24374942
[TBL] [Abstract][Full Text] [Related]
36. Reversal of Roux-en-Y Gastric Bypass for Successful Salvage of Renal Allograft.
Hrebinko K; Moroni E; Ganoza A; Puttarajappa CM; Molinari M; Sood P; El Hag M; Wijkstrom M; Tevar AD
Am Surg; 2023 Apr; 89(4):1286-1289. PubMed ID: 33631945
[TBL] [Abstract][Full Text] [Related]
37. Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption.
Stauffer JQ
Am J Dig Dis; 1977 Oct; 22(10):921-8. PubMed ID: 920694
[TBL] [Abstract][Full Text] [Related]
38. The effect of restrictive bariatric surgery on urinary stone risk factors.
Semins MJ; Asplin JR; Steele K; Assimos DG; Lingeman JE; Donahue S; Magnuson T; Schweitzer M; Matlaga BR
Urology; 2010 Oct; 76(4):826-9. PubMed ID: 20381135
[TBL] [Abstract][Full Text] [Related]
39. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
Siener R; Ebert D; Nicolay C; Hesse A
Kidney Int; 2003 Mar; 63(3):1037-43. PubMed ID: 12631085
[TBL] [Abstract][Full Text] [Related]
40. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.
Amin R; Asplin J; Jung D; Bashir M; Alshaikh A; Ratakonda S; Sharma S; Jeon S; Granja I; Matern D; Hassan H
Kidney Int; 2018 May; 93(5):1098-1107. PubMed ID: 29395336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
